Leavitt Chase C. 4
4 · Oncternal Therapeutics, Inc. · Filed Feb 23, 2023
Insider Transaction Report
Form 4
Leavitt Chase C.
General Counsel/Secretary
Transactions
- Award
Stock Option
2023-02-21+210,000→ 210,000 totalExercise: $0.96Exp: 2033-02-21→ Common Stock (210,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest on first anniversary of the date of grant, and the remaining shares subject to the option vest in 36 equal monthly installments, subject to the recipient's continued employment or service with the Issuer on each such date.